Novo Integrated Sciences Income After Taxes 2012-2024 | NVOS

Novo Integrated Sciences income after taxes from 2012 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Novo Integrated Sciences Annual Income After Taxes
(Millions of US $)
2024 $-16
2023 $-13
2022 $-33
2021 $-4
2020 $-5
2019 $0
2018 $-2
2017 $-1
2016 $0
2016 $0
2015 $-3
2014 $-1
2013 $-1
2012 $-1
2012 $-1
2011 $-2
2011 $-2
Novo Integrated Sciences Quarterly Income After Taxes
(Millions of US $)
2024-08-31 $5
2024-05-31 $-14
2024-02-29 $-3
2023-11-30 $-5
2023-08-31 $-3
2023-05-31 $-1
2023-02-28 $-5
2022-11-30 $-4
2022-08-31 $-23
2022-05-31 $-4
2022-02-28 $-5
2021-11-30 $-2
2021-08-31 $-2
2021-05-31 $0
2021-02-28 $-1
2020-11-30 $-1
2020-08-31 $-4
2020-05-31 $0
2020-02-29 $-1
2019-11-30 $0
2019-08-31 $0
2019-05-31 $0
2019-02-28 $0
2018-11-30 $0
2018-08-31 $0
2018-05-31 $0
2018-02-28 $-1
2017-11-30 $0
2017-08-31 $0
2017-05-31 $0
2017-03-31 $0
2017-02-28 $0
2016-12-31
2016-11-30 $0
2016-09-30 $0
2016-06-30 $0
2016-05-31 $0
2016-03-31 $0
2015-12-31
2015-09-30 $0
2015-06-30 $0
2015-03-31 $-2
2014-12-31
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $0
2012-09-30 $0
2012-08-31
2012-06-30 $0
2012-03-31 $0
2012-02-29 $0
2011-12-31
2011-11-30 $-1
2011-09-30 $-1
2011-08-31 $0
2011-06-30 $0
2011-05-31 $-1
2011-03-31 $-1
2011-02-28 $-1
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.001B $0.013B
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.868B 19.58
Encompass Health (EHC) United States $12.183B 25.83
DaVita (DVA) United States $10.978B 15.44
Chemed (CHE) United States $8.483B 26.66
Elanco Animal Health (ELAN) United States $6.417B 13.74
Option Care Health (OPCH) United States $5.441B 24.25
RadNet (RDNT) United States $4.587B 291.14
Amedisys (AMED) United States $3.105B 20.89
LifeStance Health (LFST) United States $2.271B 0.00
Addus HomeCare (ADUS) United States $2.054B 22.55
Astrana Health (ASTH) United States $1.524B 37.75
U.S Physical Therapy (USPH) United States $1.213B 31.31
Aveanna Healthcare Holdings (AVAH) United States $1.169B 66.56
Pennant (PNTG) United States $1.042B 38.25
Atai Life Sciences (ATAI) Germany $0.331B 0.00
Daxor (DXR) United States $0.037B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00